Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;8(1):e6-e8.
doi: 10.1016/S2352-3026(20)30362-8. Epub 2020 Dec 22.

Are we ABL to do better for children with BCR-ABL1-like acute lymphocytic leukaemia?

Affiliations
Comment

Are we ABL to do better for children with BCR-ABL1-like acute lymphocytic leukaemia?

Sarah K Tasian. Lancet Haematol. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol 2009; 10: 125–34. - PMC - PubMed
    1. Mullighan CG, Zhang J, Harvey RC, et al. JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2009; 106: 9414–18. - PMC - PubMed
    1. Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 2014; 371: 1005–15. - PMC - PubMed
    1. Harvey RC, Tasian SK. Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia. Blood Adv 2020; 4: 218–28. - PMC - PubMed
    1. den Boer ML, Cario G, Moorman AV, et al. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. Lancet Haematol 2021; 8: e55–66. - PMC - PubMed

Publication types